
About TherDose
TherDose is a Healthcare company based in Hyderabad (India) founded in 2003. Oncology-focused generic and specialty drugs are developed and manufactured. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. TherDose has raised $3.98 million across 1 funding round from investors including Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust. The company has 137 employees. TherDose was last valued at $9.98 million in September 2016. Its Indian entity Therdose Pharma Private Limited reported revenue of βΉ26.66 Cr. TherDose offers products and services including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs. Its focus areas include Pharmaceuticals and Oncology Drugs.
Company details
TherDose Pharma Pvt. Ltd. is engaged in the development and delivery of world-class chemotherapy medicines and generics, with a specialization in oncology. The company operates across various therapeutic areas, utilizing rigorous scientific principles through strong in-house research and development. Solutions are provided to diversified global markets, with over 35 generics and specialty drugs developed, alongside numerous dossiers filed in emerging markets. The commitment to affordable pricing is maintained to enhance accessibility to critical treatments.
- Headquarters Hyderabad, India
- Employees 137
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website therdose.com
- Social LinkedIn X Facebook
- Legal Name Therdose Pharma Pvt. Ltd.
- Date of Incorporation 19 Dec, 2003
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹26.66 Cr
FY 2025 · +12% YoY
- Net Loss-₹4.90 Cr
FY 2025 · -18% margin
- EBITDA-₹1.89 Cr
FY 2025 · -7% margin
- Total Equity Funding$3.98M (USD)
in 1 rounds
- Latest Funding Round$3.98M (USD), Series A
Sep 2016
- Employee Count137
Associated legal entities of TherDose
TherDose operates through Therdose Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Therdose Pharma Private Limited CIN U24239TG2003PTC042272 | Active | 19 Dec 2003 | Hyderabad, Telangana | ₹26.7 Cr | 137 | 8 | View details |
Products & Services of TherDose
TherDose offers a comprehensive portfolio of products and services, including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.
Chemotherapy medicines are developed for oncology treatment needs.
Generic drugs are produced for various therapeutic areas.
Specialty drugs are created for specific oncology requirements.
Funding Insights of TherDose
TherDose has successfully raised a total of $3.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.98 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.98M
- Total Rounds 1
- Last Round Series A β $3.98M
- First Round $3.98M
(Sep 2016)
- Investors Count 2
All 1 funding rounds of TherDose with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $3.98M | Series A | $9.98M | Hitha Palepu Irrevocable Stock Trust, Robert Pragada Irrevocable Stock Trust | β |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2016 | $9.98M | β’β’β’β’β’β’β’β’ |
Last known valuation $9.98M (Sep 2016). 2 investors in total: 2 institutional.
Investors in TherDose
TherDose has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investor details for TherDose
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Therdose Pharma Private Limited (TherDose)
Therdose Pharma Private Limited is the primary company behind TherDose. The board of Therdose Pharma Private Limited currently have 7 directors; the longest-serving is Ratna Sekhar Rao Imadabathuni, appointed in 2021. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ratna Sekhar Rao Imadabathuni DIN 00028465 | Managing Director | 12 Nov 2021 | 5 yrs | Therdose Pharma Private Limited |
| Meka Kesava Sambasiva Rao DIN 03622355 | Director | 26 Nov 2021 | 4 yrs 11 mo | Therdose Pharma Private Limited |
| Arvind Reddy Panyala DIN 08173737 | Director | 26 Nov 2021 | 4 yrs 11 mo | Therdose Pharma Private Limited |
| Mahindra Dev Imadabathuni DIN 08477374 | Whole-time director | 26 Nov 2021 | 4 yrs 11 mo | Therdose Pharma Private Limited |
| Mantena Raju Narasa DIN 02666074 | Director | 26 Nov 2021 | 4 yrs 11 mo | Therdose Pharma Private Limited |
| Raja Vakula Devi Imadabathuni DIN 00028497 | Director | 03 Oct 2022 | 4 yrs 1 mo | Therdose Pharma Private Limited |
| Narayana Raju Mantana DIN 09163239 | Director | 15 Apr 2024 | 2 yrs 7 mo | Therdose Pharma Private Limited |
People of TherDose
9 people are tracked at TherDose (4 in leadership, 5 in team); the tracked headcount is 137.
| Name | Role | Group |
|---|---|---|
| Director Operations | Leadership | |
I. R. Sekhar Rao | Managing Director | Leadership |
| Director Marketing | Leadership | |
M.k. Sambasiva Rao | Director | Leadership |
Srinivas Rao | Dy. Manager -qa | Team |
Beeravelli Rajesh | Account Assistant | Team |
Praveen Katakam | Chemist | Team |
Deepak Mamtora | Assistant Manager | Team |
Ramesh Banothu | Assistant Product Manager | Team |
Complete people profiles for TherDose
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of TherDose
Figures of Therdose Pharma Private Limited, the primary company behind TherDose, for FY 2025. Revenue was ₹26.66 Cr (+12% year on year). Net loss was -₹4.90 Cr (-18% margin). EBITDA was -₹1.89 Cr (-7% margin). Revenue has grown at a compounded annual rate of +4% over five years.
- ₹26.66 CrRevenue · FY 2025 · +12% YoY
- -₹4.90 CrNet loss · -18% margin
- -₹1.89 CrEBITDA · -7% margin
- ₹9.99 CrPaid-up capital
- 137Employees (provident fund records)
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Therdose Pharma Private Limited are on its company page.
Detailed financial statements for TherDose
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of TherDose
3 dated milestones of TherDose across 13 years, from founding to its latest funding, stage changes and deals.
- Founded TherDose is founded.
- Funding First funding round of $4.0M.
- Milestone Reaches Minicorn status.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as TherDose (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 72.52 M | 1,115 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TherDose
TherDose was founded in 2003 and raised its 1st funding round 13 years after it was founded.
TherDose is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
TherDose is a funded company, having raised a total of $3.98M across 1 funding round to date. The company's 1st funding round was a Series A of $3.98M, raised on Sep 2016.
TherDose has 137 employees.
The primary company behind TherDose, Therdose Pharma Private Limited, reported revenue of βΉ26.66 Cr for FY 2025, up 12% year on year.
TherDose Pharma Pvt. Ltd. is engaged in the development and delivery of world-class chemotherapy medicines and generics, with a specialization in oncology. The company operates across various therapeutic areas, utilizing rigorous scientific principles through strong in-house research and development. Solutions are provided to diversified global markets, with over 35 generics and specialty drugs developed, alongside numerous dossiers filed in emerging markets. The commitment to affordable pricing is maintained to enhance accessibility to critical treatments.
TherDose offers Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.
TherDose has 2 investors. Key investors include Hitha Palepu Irrevocable Stock Trust, and Robert Pragada Irrevocable Stock Trust.
The valuation of TherDose is $9.98M as of Sep 2016.
TherDose operates through Therdose Pharma Private Limited.
The legal entities of TherDose currently have 8 directors, including Meka Kesava Sambasiva Rao, Narayana Raju Mantana, Arvind Reddy Panyala and others.